The global medical industry experienced a 33% drop in company filings mentions of remote patient monitoring in Q2 2023 compared with the previous quarter, with the highest share accounted for by Medtronic with 42% year-on-year decrease, according to GlobalData’s analysis of over 74 medical company filings. GlobalData’s Remote Patient Monitoring Devices – Thematic Research report provides a thorough analysis of market opportunity, and driving factors, key trends, and leading companies in the RPM devices theme. Buy the report here.
Notably, remote patient monitoring was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of mobile and internet of things, according to GlobalData.
Of the top leading companies in the medical industry, Medtronic had the greatest increase in references for remote patient monitoring in Q2 2023, compared with the previous quarter. GlobalData identified 11 remote patient monitoring-related sentences in the company's filings - 2% of all sentences - and a decrease of 42% in Q2 2023 compared with Q2 2022. Baxter International’s mentions of remote patient monitoring rose by 100% to 4 and DexCom’s by 33% to 4 and Abbott Laboratories’s by 40% to 3.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for remote patient monitoring in Q2 2023 was 106.
For further understanding of GlobalData's Remote Patient Monitoring Devices - Thematic Research buy the report here.